You have 9 free searches left this month | for more free features.

Congenital Adrenal Hyperplasia

Showing 1 - 25 of 4,105

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fertility and Pregnancy in Classic Congenital Adrenal

Not yet recruiting
  • Classic Congenital Adrenal Hyperplasia
  • Women patients with classical congenital adrenal hyperplasia
  • Bron, France
    Endocrinology Department of Louis Pradel Hospital
Nov 22, 2023

Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia Trial (CRN04894)

Not yet recruiting
  • Congenital Adrenal Hyperplasia
  • Classic Congenital Adrenal Hyperplasia
  • (no location specified)
Jun 8, 2023

Congenital Adrenal Hyperplasia (CAH) Trial run by the NICHD (Flutamide, Letrozole, Hydrocortisone)

Active, not recruiting
  • Congenital Adrenal Hyperplasia (CAH)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Congenital Adrenal Hyperplasia Trial in London (Lu AG13909)

Recruiting
  • Congenital Adrenal Hyperplasia
  • Lu AG13909
  • London, England, United Kingdom
    University College London Hospital NHS Foundation Trust
Dec 20, 2022

Congenital Adrenal Hyperplasia Trial run by the National Institutes of Health Clinical Center (CC) (virtual educational based

Not yet recruiting
  • Congenital Adrenal Hyperplasia
  • virtual educational based transition intervention self-paced
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Salt Wasting, Hydro-sodium Balance and Fludrocortisone

Completed
  • Congenital Adrenal Hyperplasia (CAH)
    • Paris, France
      Hôpital Robert Debré
    Sep 15, 2022

    Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

    Withdrawn
    • Congenital Adrenal Hyperplasia
    • Abiraterone acetate
    • +3 more
    • Los Angeles, California
    • +3 more
    Jan 30, 2023

    Congenital Adrenal Hyperplasia Trial in Naples (Conventional Glucocorticoids (immediate release hydrocortisone, cortisone

    Recruiting
    • Congenital Adrenal Hyperplasia
    • Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
    • Dual release hydrocortisone (plenadren)
    • Naples, Italy
      Federico II University
    Mar 21, 2022

    Congenital Adrenal Hyperplasia Trial run by the (Hydrocortisone)

    Completed
    • Congenital Adrenal Hyperplasia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 17, 2022

    CAH - Congenital Adrenal Hyperplasia Trial in United States (NBI-74788)

    Completed
    • CAH - Congenital Adrenal Hyperplasia
    • San Diego, California
    • +5 more
    Jun 20, 2022

    Natural History Study of Patients With Excess Androgen

    Recruiting
    • Congenital Adrenal Hyperplasia (CAH)
    • Familial Male-Limited Precocious Puberty (FMPP)
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Congenital Adrenal Hyperplasia Trial in United States (AAV BBP-631)

      Recruiting
      • Congenital Adrenal Hyperplasia
      • AAV BBP-631
      • Los Angeles, California
      • +6 more
      Jul 29, 2022

      Congenital Adrenal Hyperplasia Trial run by the (Chronocort)

      Not yet recruiting
      • Congenital Adrenal Hyperplasia
      • Bethesda, Maryland
        National Institutes of Health Center
      Mar 18, 2022

      Gonadal Changes In Congenital Adrenal Hyperplasia Patients

      Recruiting
      • Congenital Adrenal Hyperplasia
      • Ultrasonography and MRI
      • Cairo, Egypt
        Ain Shams University
      Dec 10, 2021

      CAH - Congenital Adrenal Hyperplasia Trial in United States (NBI-74788)

      Completed
      • CAH - Congenital Adrenal Hyperplasia
      • Aurora, Colorado
      • +5 more
      Apr 5, 2022

      Congenital Adrenal Hyperplasia Trial in Morehead City (Chronocort®, Standard Care)

      Withdrawn
      • Congenital Adrenal Hyperplasia
      • Morehead City, North Carolina
        Diabetes and Endocrinology Consultants PC
      Mar 31, 2022

      Determine Eligibility for CAH-301 [NCT04783181])

      Recruiting
      • Congenital Adrenal Hyperplasia
      • Pre-Screening
      • Los Angeles, California
        Science37
      Mar 1, 2022

      Congenital Adrenal Hyperplasia, 21-Hydroxylase Deficiency, Adrenogenital Syndrome Trial run by the (Chronocort, Cortef)

      Completed
      • Congenital Adrenal Hyperplasia
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 5, 2022

      Assess Outcomes of Management of Congenital Adrenal Hyperplasia

      Not yet recruiting
      • Adrenal Hyperplasia, Congenital
      • Questionnaire
      • (no location specified)
      Jan 27, 2022

      Congenital Adrenal Hyperplasia Trial in Japan, United States (Chronocort, Cortef)

      Recruiting
      • Congenital Adrenal Hyperplasia
      • Orange, California
      • +21 more
      Nov 21, 2022

      China Adrenal Disease Registry

      Recruiting
      • Cushing Syndrome
      • +7 more
        • Shanghai, China
          Endocrinology
        Jan 28, 2022

        Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)

        Active, not recruiting
        • Congenital Adrenal Hyperplasia
        • Abiraterone acetate
        • Los Angeles, California
        • +3 more
        Feb 22, 2022

        Aldosterone-producing Adenoma and Unilateral Hyperplasia

        Not yet recruiting
        • Primary Aldosteronism Due to Aldosterone Producing Adenoma
        • Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
        • histopathology
        • Chongqing, China
          The Third Affiliated Hospital of the Third Military Medical Univ
        Jun 28, 2023

        Adrenal Diseases- Laparoscopic vs. Robotic-assisted

        Recruiting
        • Adrenal Tumor
        • +12 more
          • Olomouc, Czechia
            University hospital Olomouc
          Sep 17, 2023

          Congenital Adrenal Hyperplasia Trial in Worldwide (Crinecerfont, Placebo)

          Recruiting
          • Congenital Adrenal Hyperplasia
          • Birmingham, Alabama
          • +45 more
          Dec 9, 2022